Navigation Links
All Pets With Cancer in U.S. Provided Free Consultation
Date:11/14/2007

that the key to successful cancer treatment is an early diagnosis and effective treatment regime. Sadly, qualified cancer specialists are not always available locally. This may cause pet owners and their local veterinarians to not seek specialized treatment. Or, the costs may be high and the travel time for treatments may be prohibitive for some pet owners.

With this new initiative, local veterinarians are encouraged to visit the Pets Best web site and click on a special web site created by Pets Best, or go directly to http://www.petcancerfoundation.org to obtain the free initial consultation from a board-certified veterinary oncologist who will identify what treatments are the most effective for each specific cancer. Although the Pet Cancer Foundation web site is for pet owners, the consultation can only be provided to a licensed veterinarian. The web site, however, does provide information on cancer in pets for consumers.

"All too often, cancer treatments for pets do not happen because of the hassle of taking your pet elsewhere, sometimes requiring driving long distances for specialized treatments that may be needed weekly or even more often," says Dr. Villalobos. "Or people have to hospitalize their pets far from home for weeks or months."

"Now with this process, many cancer treatments can be successfully implemented, monitored and adapted by a person's own veterinarian with the benefit of a cancer specialist assisting in every step," she adds.

In the broader perspective, this initiative was created to keep pets living longer, healthier lives and enable them to bring joy to their families. "And that is our mission at Pets Best," stated Dr. Stephens. "We strive to provide the reimbursement for the best pet care possible."

This effort by Dr. Jack Stephens and Pets Best Insurance is in addition to the pledge of $1 million to the Morris Animal Foundation (MAF) canine cancer c
'/>"/>

SOURCE Pets Best Insurance
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2008)...ents freedom of movement, better quality of life ,... An automated artificial kidney that can be worn ...at the insulin pump is to diabetes patients. , ...orks better than conventional dialysis, according ...xperimental Nephrology . , "What,s really new a...
(Date:7/25/2008)...wswire-USNewswire/ -- Anthony Shih,M.D., M.P.H., ...e President,of Strategic Planning, after a two-yea...ation committed to improving U.S. health system pe...ram on Health Care Quality,Improvement and Efficie.../20080725/DC28791LOGO ), Board-certified in publ...
(Date:7/25/2008)...troviral therapy may be due to genetic factors , ...ew study challenges the long-held belief that the ...s ability to restore itself after HIV patients are... (HAART). , From 50 percent to 90 percent of HI...Intravenous drug use is the main cause of both typ...
(Date:7/25/2008)...sumers tips and encourages them to, ,Speak Up,(TM...uly 25 /PRNewswire-USNewswire/ -- The Pennsylvania... Patient Safety Day" which,is a national effort to...ate fully in their healthcare by asking questions ...ry or illness., "We understand the important role...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3
...urprisingly few doctors are ‘logged’ in. For year... Internet technology and result in doctor- patie...ed. Research published in Wall Street Journal Onl...t of adults receive e-mail from their doctors. An...
...taking a break has helped a doctor here to conduct...hnique of single hole surgery. Doctor Ajay Prakas...pital in Agra at around 10 p.m. Thursday night and...ill 10 a.m. Friday morning, removing 45 gall bladd...
...f a woman’s reproductive years, usually occurs aro...men experience //early menopause. Early menopause ... of health problems, including osteoporosis and ca...ssue of Mayo Clinic Women’s HealthSource describes...
...se by nearly 22 percent between 2000 and 2004 – fr... and Numbers// from the Agency for Healthcare Rese... percent during the previous seven years. AHRQ f... every five admissions resulted from people being ...
Other Medicine News:Health News:Doctors –you’ve Got Ma 2
(Date:7/24/2008)...Newswire/ -- Ortho-McNeil Neurologics, a,division ...ounced today,that the U.S. Food and Drug Administr...TOPAMAX(R) (topiramate), based on studies submitte...nvestigate the use of TOPAMAX,in pediatric patient..., In addition to granting pediatric exclusivity, ...
(Date:7/24/2008)...am Speeds Oncology Patient Accrual, DENVER, July ...nagement,Organization (RMO), has contracted with f...search and site management services for their,clin...t strategy. The new,trials include the following d...oma, Metastatic Breast Cancer, Metastatic Sarcoma,...
(Date:7/23/2008)...tion in July print edition of Clinical ...IS, July 23 /- A Roche Diagnostics-sp...al pro-B-type natriuretic peptide,(NT-proBNP) conf...atification in predicting the risk of cardiovascul... non-steroidal anti-inflammatory drugs of,the COX ...
(Date:7/23/2008)...swire/ -- InCode BioPharmaceutics, Inc.,an emergi...linical test,results demonstrating the utility of ...of the rare chronic blood disorder paroxysmal noct...ill be presented at the XXII,International Complem...2008., The only treatment currently available for...
Breaking Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 1Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 2Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 3Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 4Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 5Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 6Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 7Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 8Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 9Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 10NightHawk Radiology Holdings Inc to Host Conference Call to Discuss First Quarter 2008 Earnings Results 17591 1NightHawk Radiology Holdings Inc to Host Conference Call to Discuss First Quarter 2008 Earnings Results 17591 2AARP Commends Illinois U S Reps for Voting to Protect People in Medicaid 17587 1AARP Commends Illinois U S Reps for Voting to Protect People in Medicaid 17587 2The spring in your step is more than just a good mood 17584 1The spring in your step is more than just a good mood 17584 2
...SINESS WIRE)--Jun 5, 2007 - NovaDel Pharma,Inc. (A...loping,oral spray formulations for a broad range o...o clinical studies comparing zolpidem,oral spray w...cokinetic (PK), pharmacodynamic (PD) and safety ob...as Ambien(R), a leading,drug for the treatment of ...
... III Study Results Presented At ASCO -- , CHICAGO ...ith,pegylated interferon alfa-2b in stage III mela...apse-free survival (RFS),according to the results...atients with stage III melanoma. Results of the Ph...r the Research and,Treatment of Cancer (EORTC) and...
Other Medicine Technology:NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 2Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 3Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 4Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 5
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: